Coeptis Therapeutics Inc. (COEP)
NASDAQ: COEP
· Real-Time Price · USD
13.71
0.10 (0.73%)
At close: Aug 21, 2025, 10:00 AM
Coeptis Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 200.68K | 62.87K | 1.86M | n/a | n/a | n/a | 1.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.89K | n/a | 75K |
Cost of Revenue | 45.16K | 45.16K | 931.73K | 431.3K | 250.21K | 250.21K | 250.31K | 250.31K | 250.31K | 250.31K | 250.35K | n/a | n/a | n/a | n/a | 1.49K | n/a | n/a |
Gross Profit | 155.52K | 17.72K | 931.73K | -431.3K | -250.21K | -250.21K | 1.25M | -250.31K | -250.31K | -250.31K | -250.35K | n/a | n/a | n/a | n/a | 8.4K | n/a | 75K |
Operating Income | -4.52M | -4.06M | -2.16M | -2.14M | -2.83M | -2.92M | -3.37M | -7.83M | -3.64M | -6.45M | -3.04M | -5.57M | -9.81M | -15.77M | -2.96M | -6.95M | -2.62M | -1.7M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 146.06K | n/a | n/a | 1.92K | n/a | n/a | n/a |
Pretax Income | -4.33M | -3.42M | -3.01M | -1.83M | -3.04M | -3M | -3.76M | -6.26M | -3.11M | -7.87M | -2.94M | -5.65M | -9.8M | -19.18M | -2.84M | -5.95M | -2.71M | -1.95M |
Net Income | -3.53M | -3.06M | -1.95M | -1.83M | -3.04M | -3M | -3.76M | -6.26M | -3.11M | -9.26M | -2.84M | -5.73M | -9.8M | -3,408.6B | -2.84M | -5.95M | -2.71M | -1.95M |
Selling & General & Admin | 4.14M | 375.57K | 4.21M | 1.08M | 2.18M | 1.9M | 2.1M | 2.83M | 3.22M | 6.42M | 3.22M | 5.49M | 9.75M | 15.72M | 3.04M | 6.76M | 2.58M | 1.74M |
Research & Development | 290.31K | 86.66K | 343.88K | 811.78K | 398.82K | 777.07K | 1.01M | 4.98M | 377.04K | 25.74K | 20.89K | 20.89K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 250K | 3.61M | n/a | -181.3K | n/a | n/a | n/a | -38.6K | n/a | 35.00 | 318.7K | n/a | -5K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.68M | 4.07M | 4.55M | 1.71M | 2.58M | 2.67M | 3.12M | 7.81M | 3.6M | 6.45M | 3.22M | 5.51M | 9.75M | 15.72M | 3.04M | 6.76M | 2.58M | 1.74M |
Interest Expense | 67.79K | -71.49K | 78.63K | 50.93K | 66.06K | 200.5K | 13.83K | 19.8K | 42.64K | 31.42K | 42.34K | 56.42K | 63.83K | 55.82K | -77.33K | 188.56K | 43.1K | 34.74K |
Selling & Marketing Expenses | n/a | 106.5K | -5K | n/a | 5K | 1.63M | n/a | 12.41K | 300.00 | n/a | 1.42K | 2.86K | 4.05K | n/a | n/a | n/a | n/a | 2.92K |
Cost & Expenses | 4.72M | 4.12M | 2.16M | 2.14M | 2.83M | 2.92M | 3.37M | 7.81M | 3.6M | 6.45M | 3.22M | 5.51M | 9.75M | 15.72M | 3.04M | 6.76M | 2.58M | 1.74M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -1.41M | -18.8K | 42.64K | 1.39M | -100.29K | 80K | 58.83K | 3,408.6B | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.71M | 3.07M | 1.92M | 39.81M | 37.57M | 35.54M | 35.33M | 26.65M | 21.81M | 20.08M | 14.3M | 19.52M | 20.44M | 20.44M | 9.38M | 20.44M | 20.44M | 20.44M |
Shares Outstanding (Diluted) | 3.71M | 3.07M | 1.92M | 39.81M | 37.57M | 35.54M | 35.33M | 26.65M | 21.81M | 20.08M | 14.3M | 20.44M | 20.44M | 20.44M | 9.38M | 20.44M | 20.44M | 20.44M |
EPS (Basic) | -0.95 | -0.99 | 4.09 | -0.05 | -0.08 | -0.08 | -0.11 | -0.23 | -0.14 | -0.46 | -0.2 | -0.29 | -0.48 | -166.75K | -0.3 | -0.29 | -0.13 | -0.1 |
EPS (Diluted) | -0.95 | -0.99 | 4.09 | -0.05 | -0.08 | -0.08 | -0.11 | -0.23 | -0.14 | -0.46 | -0.2 | -0.28 | -0.48 | -166.75K | -0.3 | -0.29 | -0.13 | -0.1 |
EBITDA | -3.96M | -4.06M | -2.67M | -1.5M | -2.72M | -2.55M | -3.49M | -6.08M | -2.91M | -7.68M | -2.65M | -5.34M | -9.49M | -15.46M | -2.47M | -6.95M | -2.67M | -1.91M |
EBIT | -4.27M | -3.35M | -2.93M | -1.78M | -2.97M | -2.8M | -4.01M | -6.33M | -3.16M | -7.93M | -2.9M | -5.59M | -9.74M | -19.12M | -2.92M | -5.76M | -2.67M | -1.92M |
Depreciation & Amortization | 305.53K | 305.3K | 259.98K | 278.23K | 250.21K | 250.21K | 250.31K | 250.31K | 250.31K | 250.31K | 250.35K | 250.35K | 250.35K | 250.35K | 446.2K | 366.00 | 367.00 | 481.00 |